CECOG Academy

www.cecog.org

 

CECOG Academy
L

SABCS Updates on Targeting Mutations in MBC Treatment: PIK3CA, AKT & HER2 Mutations and Available Therapies

By CECOG Academy FEATURING Leticia De Mattos-Arruda
By CECOG Academy FEATURING Leticia De Mattos-Arruda
124 views
March 29, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

13:36
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss
Post SABCS Webinar
25:58

SABCS Updates on Targeting Mutations in MBC Treatment: PIK3CA, AKT &…

CECOG Academy

L. De Mattos-Arruda

124 views
16:33

SABCS Updates on CDK4/6i in HR+, HER2- EBC: Is It Time to Adopt in A…

CECOG Academy

E. de Azambuja

183 views
15:56

Immune CPIs in mTNBC: What, When and Where?

CECOG Academy

E. de Azambuja

131 views
25:24

SABCS Updates on TNBC: Chemotherapy, Biomarkers, PARPi, AKTi, CDK4/6…

CECOG Academy

R. Bartsch

184 views